| [1] Kuzniatsova N., Pamukcu B., Lip G. Y. H., Therapy, 2011, 8(6), 681—689[2] Patel P. B., Patel K. C., Mehta H. R., Int. Res. J. Pharm, 2011, 2(3), 59—65[3] Patel P. D., Bhuriya R., Patel D. D., Arora B. L., Singh P. P., Arora R. R., Vasc. Health Risk Manage, 2009, 5, 635—642[4] Dobromir D., Stanley N., Lancet, 2010, 375, 1212—1223[5] Singh B. N., Capucci A., Radzik D., Hohnloser S. N., Engl. J. Med., 2007, 357, 987—999[6] Gubin J., Lucchetti J., Inion H., Chatelain P., Rosseels G., Kilenyi S., Preparation of Benzofurans, Benzothiophenes, Indoles, and Indolizines as Cardiovascular Agent, EP 0471609, 1991-08-06[7] Biard M., 2-Butyl-3-(4-Benzoyl)-5-Nitro-Benzofuran Hydrochlorides and Preparation Thereof, WO 2002048078, 2001-12-10[8] Fino N., Leroy C., A Process for the Preparation of 2-Butyl-5-Benzofuran as an Intermediate for the Synthesis of Dronedarone,WO 2002048132, 2001-12-10[9] Gutman A., Nisnevich G., Yudovitch L., Process for the Preparation of Dronedarone, WO 2003040120, 2002-11-06[10] Eklund L., Process for the Preparation of Benzofuran via Cyclocondensation of Phenylhydroxylamines with Ketones, WO 2009044143, 2008-10-02[11] Fu Q. Q., Yang T. B., Zhao M. X., Novel Method for Preparing Dronedarone, CN 101993427, 2009-08-26(付清泉, 杨涛波, 赵茂先. 一种制备决奈达隆的新方法, CN 101993427, 2009-08-26)[12] Friesz A., Dombrady Z., Csatarine N. M., Process for Preparation of Dronedarone, WO 2011070380, 2010-11-23[13] Friesz A., Csatarinenagy M., An Improved Process for the Preparation of Dronedarone via Novel Intermediates, WO 2011083346, 2010-12-15[14] Zhai F. M., Chen Y. J., Hu Q., Method for Preparation of Antiarrhythmic Drug Dronedarone, CN 102180848, 2010-12-31(翟富民, 陈拥军, 胡全. 一种新型抗心律失常药决奈达隆的制备方法, CN 102180848, 2010-12-31)[15] Sada M., Nardi A., Maiorana S., Novel Process for the Manufacture of Dronedarone, WO 2011104591, 2011-01-26[16] Giri R. L., Mohite V. D., Kambhampati S., Chitturi T. R., Thennati R., A Process for the Preparation of Butyldibutylaminopropoxyenzoylbenzofuranylmethanesulfonamide Hydrochloride, WO 2012120544, 2012-09-13[17] Hivarekar R. R., Deshmukh S. S., Tripathy N. K., Org. Process Res. Dev., 2012, 16(4), 677—681[18] Baragona F., Lomberget T., Lo P. E., Barret R., Diana P., Montalbano A., Duchamp C., Henriques N., J. Med. Chem., 1999, 42(6), 1041—1052[19] Baragona F., Tetrahedron, 2011, 67(45), 8731—8739[20] Payne J. E., Smith N. D., Parent S. D., Lei W., Salts of Pyridine Derivatives as Inhibitors Histone Deacetylase and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of Disease, WO 2008073733, 2008-06-19[21] Gibbs C. F., J. Am. Chem. Soc., 1934, 56(3), 725—727[22] Adams R., Looker J. H., J. Am. Chem. Soc., 1951, 73(3), 1145—1149[23] Wang Y., Frank S. G. J., J. Org. Chem., 2001, 66(25), 8293—8296 |
